Genmab — Januar 2017
-
-
Actelion-split en del af nye J&J-forhandlinger
Anden runde i forhandlingerne mellem Actelion og Johnson & Johnson er nu i gang. Det nye forhandlingsoplæg indeholder blandt andet et nyt børsnoteret spinout, lyder det fra kilder.
(medwatch.dk)
-
JP Morgan hæver til 1.350.
-
Var det den vi havde i går?
-
Tak..Det er svært at følge med i efterhånden.
-
Der er ihvertfald en positiv tendens a spore, m.h.t analytiker og kursmål https://markets.ft.com/data/equities/tearsheet/forecasts?s=GEN:CPH
-
Logisk..Udlandet opjusterer og udlandet køber.
-
Måske Florian får ret
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind